Scientific article
English

Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort

Published inAtherosclerosis, vol. 284, p. 253-259
Publication date2019
Abstract

Better characterization of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) profile is currently needed to tailor appropriate lipid-lowering strategies in HIV patients.

Funding
Citation (ISO format)
GENCER, Baris et al. Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. In: Atherosclerosis, 2019, vol. 284, p. 253–259. doi: 10.1016/j.atherosclerosis.2019.02.015
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0021-9150
396views
1downloads

Technical informations

Creation14/08/2019 15:01:00
First validation14/08/2019 15:01:00
Update time24/01/2025 13:54:35
Status update24/01/2025 13:54:35
Last indexation24/01/2025 13:58:16
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack